Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,944,971
-
Share change
-
+5,714,836
-
Total reported value
-
$900,322,578
-
Price per share
-
$37.60
-
Number of holders
-
93
-
Value change
-
+$213,437,027
-
Number of buys
-
69
-
Number of sells
-
20
Institutional Holders of TURNING POINT THERAPEUTICS I - COM (TPTX) as of Q3 2019
As of 30 Sep 2019,
TURNING POINT THERAPEUTICS I - COM (TPTX) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,944,971 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, Foresite Capital Management IV, LLC, venBio Partners LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.